Crescent Capital BDC (CCAP) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
The annual meeting will be held virtually on May 15, 2026, with full participation rights for shareholders.
Shareholders will vote on electing two Class II Directors and ratifying Ernst & Young LLP as the independent auditor for 2026.
The Board unanimously recommends voting for both director nominees and the auditor ratification.
Proxy materials and the 2025 annual report are available online, and multiple voting methods are provided.
Voting matters and shareholder proposals
Proposals include electing Susan Yun Lee and Michael S. Segal as Class II Directors until 2029 and ratifying E&Y as auditor for 2026.
The Board and all independent directors recommend voting for both proposals.
Shareholders may submit additional proposals for the 2027 meeting by December 2, 2026, following advance notice requirements.
Board of directors and corporate governance
The Board consists of six directors, five of whom are independent; committees include Audit, Nominating, and Compensation.
Annual self-assessment and periodic review of leadership structure are conducted.
All directors attended at least 75% of meetings in 2025.
The Nominating Committee considers diversity of skills and experience but has no formal diversity policy.
Latest events from Crescent Capital BDC
- Net investment income fell to $0.36 per share as NAV declined and risk management remained a focus.CCAP
Q2 2026 - Directors were elected for three-year terms and the auditor was ratified with no shareholder questions.CCAP
AGM 2026 - Net investment income and NAV per share declined, with fee reductions and special dividends announced.CCAP
Q1 2026 - Virtual meeting to elect directors and ratify auditor, with online voting available.CCAP
Proxy filing - Q4 net investment income covered the dividend, with NAV at $19.10 and a strong, diversified portfolio.CCAP
Q4 2025 - Net investment income per share was $0.46 for Q3 2025, with NAV per share at $19.28.CCAP
Q3 2025 - Q3 net investment income rose to $0.64 per share, with strong liquidity and low non-accruals.CCAP
Q3 2024 - Q2 2024 NII reached $0.59/share, NAV hit $20.30, with strong liquidity and low nonaccruals.CCAP
Q2 2024 - Q4 2024 featured stable NAV, strong liquidity, robust dividends, and a diversified portfolio.CCAP
Q4 2024